Infectious diseases systemic

NIAID Systems Biology for National Institute of Allergy and Infectious Diseases Systems Biology Infectious Diseases Research Program for Infectious Disease Research comprising four centers ... 

Tools for rule-based expert systems (as well as manual methods) should evaluate the consistency and completeness of the rules. The TEIRESIAS program (Davis 1976) linked to the MYCIN infectious disease system was one of the first attempts to develop an automated verification tool. Later work by Suwa et al. (1982) for the ONCOCIN (clinical oncology) system examined a rule set as it was read into the system. This rule checker assumes that for each combination of attribute values appearing in the antecedent a corresponding rule exists. 

The Control of Industrial Pollution Water Quality and Health Aspects of the Chemistry and Analysis of Substances of Concern in the Water Cycle The Role of Wastewater Treatment Processes in the Removal of Toxic Pollutants Sewage and Sewage Sludge Treatment The Chemistry of Metal Pollutants in Water Effects of Pollutants on the Aquatic Environment Important Air Pollutants and Their Chemical Analysis Pollutant Pathways and Modelling of Air Pollution Legislation and the Control of Air Pollution Catalyst Systems for Emission Control from Motor Vehicles Evaluating Pollution Effects on Plant Productivity A Cautionary Tale Epidemics of Non-infectious Disease Systems Methods in the Evaluation of Environmental Pollution Problems Organometallic Compounds in the Environment. 

These two examples hint at a few of the reasons for the importance of knowledge-based systems. A medical faciHty may handle hundreds of infectious disease cases a year. Speedy, accurate diagnosis of these cases, aided by a system such as Mycin, may help the medical faciHty handle more patients, more effectively. Likewise, configuring large computer systems composed of many components can be a time-consuming and error-prone task. 

In infectious disease compounds such as ANA975 (phase I trials) and Resiquimod (phase II trails) have been developed to target Hepatitis C and genital herpes, respectively. DRS954 is a TLR-7 and 9 antagonist in pre-clinical trials for Systemic Lupus Erythematosus (SLE). 

Tuberculosis is a major health problem throughout the world, infecting more than 8 million individuals each year. It is die world s leading cause of death from infectious disease Individuals living in crowded conditions, those widi compromised immune systems, and individuals widi debilitative conditions are especially susceptible to tuberculosis. 

Lopez-Berestein, G. (1989). Treatment of systemic fungal infections with liposomal-amphotericin B, in Liposomes in the Therapy of Infectious Diseases and Cancer (G. Lopez-Berestein and I. J. Fidler, eds.), Alan R. Liss, New York, pp. 317-327. 

FIGURE 71-1. Pathogenesis of infective endocarditis. (From Scheld W. In Atlas of Infectious Diseases External Manifestations of Systemic Infections. Philadelphia Current Medicine, Inc. Copyright 1997. Used with permission.)... 

Vaccination to induce an adaptive immune response is expected for a broad range of infectious diseases and cancers. Traditional vaccines are mainly composed of live attenuated viruses, whole inactivated pathogens, or inactivated bacterial toxins. In general, these approaches have been successful for developing vaccines that can induce an immune response based on antigen-specific antibody and cytotoxic T lymphocyte (CTL) responses, which kill host cells infected with intracellular organisms (Fig. 1) [1,2], One of the most important current issues in vaccinology is the need for new adjuvants (immunostimulants) and delivery systems. Many of the vaccines currently in development are based on purified subunits, recombinant... 

BV being an infectious disease, antibiotics represent the logical therapeutic approach [39]. However, a high spontaneous cure rate in some patients without symptoms has been found [40], For this reason, placebo-controlled groups are recommended for antibiotic effectiveness trials. Besides systemic toxicity [4], antibiotic treatment... 

Conventional pharmaceutical development has been estimated to costs roughly between 100 million and 800 million per product, and takes over 12 years. The development of conventional vaccines may be somewhat less costly, although new recombinant DNA-derived subunit vaccines produced in fermentation-based systems are likely to be similar to protein pharmaceuticals in development costs. At present, none of the major pharmaceutical companies is directing funding towards the development of plant-derived vaccines for infectious diseases. This may reflect ... 

Moreover,bioactive lipids maybe considered dual messengers they modulate cell functions as messengers and they become part of the response of the nervous tissue to injury, broadly referred to as the inflammatory response. This response occurs in ischemia-reperfusion damage associated with stroke, various forms of neurotrauma, infectious diseases and neurodegenerative diseases such as Alzheimer s disease. Inflammation in the nervous system differs from that in other tissues. If the blood-brain barrier is broken, blood-borne inflammatory cells (e.g. polymorphonuclear leukocytes, monocytes, macrophages) invade the intercellular space and glial cells are activated, particularly microglia, which play a prominent role in the inflammatory response. These responses may... 

The major gap in clarifying the shape of the dose-response curve (i.e., between immune response and disease) is a lack of large scale epidemiological studies in populations with mild-to moderate immunodeficiency that have been monitored simultaneously for immune system parameters and clinical disease. Attempts in conducting such studies will be complicated by many non-immune factors which can affect infectious disease incidences. 

---